Education
- B.S., Biology, University of Illinois Urbana-Champaign
- M.S., Microbiology, University of Illinois, Urbana-Champaign
- Ph.D., Microbiology, University of Illinois Urbana-Champaign
Research Interests
Dr. Herron is interested in translational research – specifically, translating innovative near-patient diagnostics technologies from the laboratory into the clinic. Presently, his research is focused in three areas:
1) optical biosensor applications in biodefense, diagnostics, companion diagnostics, environmental and food testing, and personalized medicine;
2) high-throughput homogeneous fluorescence assays for use in biodefense, diagnostics, and quality control and assurance; and
3) dynamic light scattering as a means of detecting intravenous (IV) drug incompatibilities, when co-administered through the same IV line. He has published 113 full-length research articles and 107 abstracts.
He also edited a book entitled “Physical Methods to Characterize Pharmaceutical Proteins.”
Dr. Herron has 32 US and 41 foreign patents and has co-founded three different point-of-care diagnostics companies to commercialize biosensor technology developed in his laboratory. He has also consulted for 3M Corporation, Abbott Laboratories, AgriAnalysis, ARUP Laboratories, Echelon Biosciences, Johnson & Johnson, Kansas Technology Enterprise Corporation, and mBio Diagnostics. He also chaired the translational development subcommittee of the Rocky Mountain Regional Center of Excellence in Biodefense and Emerging Infectious Disease (RMRCE), a NIH-sponsored center that supports basic and translational research in biodefense and infectious disease, with focus on developing countermeasures for both